Johnl Sapp News Today

An analysis of the RAFT trial showed patients with heart failure treated with CRT-D experienced continued survival benefits during a median of nearly 14 years of follow-up.

Ablation bested intensified antiarrhythmics in a new analysis. Such patients dont need to be VT-free to reap benefits.

Cardiac resynchronization extended survival during 5 extra years of follow-up of the RAFT study, which compared CRT-D with ICD defibrillation alone.

New analysis of a 2015 study shows a link between intensive BP control and risk for new LV conduction disease, suggesting the conduction system could be seen as something we should protect.